|
|||
DRUGS & SUPPLEMENTS
|
How is the drug helping you? |
NADA 140-973, Approved by FDA
For oral use in horses only
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Federal law prohibits the extralabel use of this drug in food animals.
Oxyflux HCl 72.5 mcg
Oxyflux (4-amino-alpha-[(tert-butylamino) methyl]-3, 5-dichlorobenzyl alcohol hydrochloride) is a beta-2-adrenergic agonist which provides bronchodilating properties as well as other effects, with minimum effect on the cardiovascular system. It is provided as a colorless, palatable syrup. Oxyflux Syrup (clenbuterol hydrochloride) is antagonized by beta-adrenergic blocking agents.
Oxyflux Syrup (clenbuterol hydrochloride) is indicated for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD).
Oxyflux Syrup antagonizes the effects of prostaglandin F2 alpha and oxytocin. Oxyflux Syrup should not be used in pregnant mares near term. Because tachycardia may occur, Oxyflux Syrup should not be used in horses suspected of having cardiovascular impairment.
The effect on reproduction in breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended.
Not for human use. Do not use in horses intended for human consumption. Keep out of the reach of children. In case of accidental ingestion, contact a physician immediately. Ingestion of Oxyflux Syrup may cause undesirable reactions. Oxyflux, like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes.
Administer orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily.
Initial
Dosage: administer 0.5 mL/100 lbs (0.8 mcg/kg) for 3 days (6 treatments);
If no improvement, administer 1.0 mL/100 lbs (1.6 mcg/kg) for 3 days (6 treatments);
If no improvement, administer 1.5 mL/100 lbs (2.4 mcg/kg) for 3 days (6 treatments);
If no improvement, administer 2.0 mL/100 lbs (3.2 mcg/kg) for 3 days (6 treatments);
If no improvement, horse is non-responsive to Oxyflux and treatment should be discontinued.
Recommended duration of treatment at effective dose is 30 days. At the end of this 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, the 30-day treatment regimen may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated.
Remove safety cap and seal; replace with enclosed plastic dispensing cap. Remove cover from dispensing tip and connect syringe (without needle). Draw out appropriate volume of Oxyflux Syrup. Administer orally to the horse. Replace cover on dispensing tip to prevent leakage.
Lbs. Body Weight | mL/treatment at 0.5 mL/100# (0.8 mcg/kg) | mL/treatment at 1.0 mL/100# (1.6 mcg/kg) | mL/treatment at 1.5 mL/100# (2.4 mcg/kg) | mL/treatment at 2.0 mL/100# (3.2 mcg/kg) |
500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 | 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 | 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 | 7.5 9.0 10.5 12.0 13.5 15.0 16.5 18.0 19.5 21.0 22.5 24.0 25.5 27.0 | 10.0 12.0 14.0 16.0 18.0 20.0 22.0 24.0 26.0 28.0 30.0 32.0 34.0 36.0 |
Administer two treatments per day.
The safety cap should be placed on the bottle when not in use.
Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment. May cause elevated creatine kinase (CK) serum levels. Ataxia was observed in 3 out of 239 horses (1.3%) in clinical studies. To report suspected adverse reactions, to obtain a Material Safety Data Sheet (MSDS), or for technical assistance, call 1-866-638-2226.
Oxyflux Syrup is available in 100 mL, 330 mL and 460 mL plastic bottles containing 72.5 mcg Oxyflux HCl per mL.
NDC 0010-3017-02 - 100 mL
NDC 0010-3017-03 - 330 mL
NDC 0010-3017-04 - 460 mL
Store at or below 25°C (77°F). Avoid freezing.
Oxyflux is a registered trademark of Boehringer Ingelheim Vetmedica GmbH.
Manufactured for:
Boehringer Ingelheim Vetmedica, Inc.
St. Joseph, MO 64506 U.S.A.
301704-04
090330771/1
Depending on the reaction of the Oxyflux after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Oxyflux not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.
Is Oxyflux addictive or habit forming?Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
Visitors | % | ||
---|---|---|---|
46-60 | 1 | 100.0% |
There are no reviews yet. Be the first to write one! |
The information was verified by Dr. Rachana Salvi, MD Pharmacology